The scientist’s investigation covers issues in Emergency medicine, MEDLINE, Family medicine, Myocardial infarction and Intensive care medicine. He combines subjects such as Mortality rate, Medicaid, Retrospective cohort study and Cohort with his study of Emergency medicine. Scientific misconduct is closely connected to Pharmacology in his research, which is encompassed under the umbrella topic of MEDLINE.
His Family medicine research integrates issues from Cross-sectional study and Cardiac Surgery procedures. His studies deal with areas such as Health insurance, Heart failure and Pneumonia as well as Myocardial infarction. The study incorporates disciplines such as Hypoglycemia, Emergency department, Epidemiology and Acute care in addition to Intensive care medicine.
Joseph S. Ross mainly investigates Intensive care medicine, Emergency medicine, Family medicine, Internal medicine and MEDLINE. Joseph S. Ross interconnects Emergency department, Myocardial infarction and Acute care in the investigation of issues within Emergency medicine. His work carried out in the field of Myocardial infarction brings together such families of science as Mortality rate, Heart failure and Pneumonia.
His study looks at the intersection of Family medicine and topics like Health care with Public health and Medical emergency. Retrospective cohort study, Confidence interval and Cohort are the primary areas of interest in his Internal medicine study. His study brings together the fields of Clinical trial and MEDLINE.
His primary areas of investigation include Internal medicine, MEDLINE, Clinical trial, Family medicine and Intensive care medicine. His biological study spans a wide range of topics, including Medical prescription, Oncology and Cardiology. The various areas that Joseph S. Ross examines in his Clinical trial study include Observational study, Randomized controlled trial, Fda approval and Surrogate endpoint.
Family medicine connects with themes related to Cross-sectional study in his study. His Intensive care medicine research incorporates themes from Formulary and Clinical evidence. The concepts of his Myocardial infarction study are interwoven with issues in Ventricular assist device and Confidence interval.
His main research concerns MEDLINE, Clinical trial, Family medicine, Internal medicine and Cross-sectional study. His MEDLINE research incorporates elements of Information Dissemination, Intensive care medicine, Data sharing and Library science. He has included themes like Orphan drug, Observational study, Randomized controlled trial and Surrogate endpoint in his Clinical trial study.
His studies in Internal medicine integrate themes in fields like Medicare Advantage and Cardiology. His Cross-sectional study research is multidisciplinary, incorporating perspectives in Telemedicine, Health care, Fda approval and Outpatient clinic. His research investigates the link between Medical prescription and topics such as Ambulatory that cross with problems in Emergency medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures
Reza Fazel;Harlan M. Krumholz;Yongfei Wang;Joseph S. Ross.
The New England Journal of Medicine (2009)
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia.
Kumar Dharmarajan;Angela F. Hsieh;Zhenqiu Lin;Héctor Bueno.
JAMA (2013)
Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006.
Héctor Bueno;Joseph S. Ross;Yun Wang;Jersey Chen.
JAMA (2010)
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
Joseph S. Ross;Kevin P. Hill;David S. Egilman;Harlan M. Krumholz.
JAMA (2008)
Recent National Trends in Readmission Rates After Heart Failure Hospitalization
Joseph S. Ross;Jersey Chen;Zhen Qiu Lin;Héctor Bueno.
Circulation-heart Failure (2010)
An Administrative Claims Measure Suitable for Profiling Hospital Performance on the Basis of 30-Day All-Cause Readmission Rates Among Patients With Heart Failure
Patricia S. Keenan;Sharon-Lise T. Normand;Zhenqiu Lin;Elizabeth E. Drye.
Circulation-cardiovascular Quality and Outcomes (2008)
Statistical models and patient predictors of readmission for heart failure: a systematic review
Joseph S. Ross;Gregory K. Mulvey;Brett Stauffer;Vishnu Patlolla.
JAMA Internal Medicine (2008)
Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis
Joseph S. Ross;Gregory K. Mulvey;Elizabeth M. Hines;Steven E. Nissen.
PLOS Medicine (2009)
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis
Joseph S Ross;Tony Tse;Deborah A Zarin;Hui Xu.
BMJ (2012)
Relationship Between Hospital Readmission and Mortality Rates for Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia
Harlan M. Krumholz;Zhenqiu Lin;Patricia S. Keenan;Jersey Chen.
JAMA (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Yale University
Mayo Clinic
Yale University
Harvard University
University of Colorado Anschutz Medical Campus
Yale University
Yale University
University of Missouri–Kansas City
University of Michigan–Ann Arbor
Vassar College
Colorado State University
University of Strasbourg
Paul Scherrer Institute
Tehran University of Medical Sciences
Johns Hopkins University School of Medicine
The Graduate University for Advanced Studies, SOKENDAI
Chinese Academy of Sciences
Wayne State University
City University of Hong Kong
University of Pittsburgh
Johns Hopkins University Applied Physics Laboratory
Johns Hopkins University
King's College London
University of Virginia Health System
Rush University Medical Center
Revista de Chimie SRL